Advanced searches left 3/3

Heart Failure - Wiley Online Library

Summarized by Plex Scholar
Last Updated: 19 June 2022

* If you want to update the article please login/register

Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction

" Aims Atrial fibrillation is a common comorbid condition in heart failure with maintained ejection portion. The impact of AF on heart failure worsening in HFpEF has not been well described. This research investigated exactly how AF customizes the scientific trajectory of HFpEF patients after a hospital stay for decompensated HF. Methods and results We stratified HFpEF topics by AF medical diagnosis and done longitudinal evaluation to contrast risk for HF a hospital stay after index hospitalization for decompensated HF. Subjects with AF were older, more frequently male, and had greater left atrial size compared to those without AF. Topics with AF had a higher risk for HF hospitalization than their equivalents without AF; this relationship remained significant adhering to multivariable competing risk regression with tendency score weighting. Final thoughts Atrial fibrillation is an independent risk element for HF rehospitalization in HFpEF. ".

Source link: https://onlinelibrary.wiley.com/doi/10.1002/ehf2.13836


Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: A position statement from the Heart Failure Association of the European Society of Cardiology

" Knowledge on risk forecasters of event heart failure in patients with type \ u20102 diabetes is crucial given the frequent conjunction of both conditions and the truth that T2D doubles the risk of case HF. On the other hand, the diagnostic and prognostic efficiency of well-known CV biomarkers may be changed by the visibility of T2D. ".

Source link: https://onlinelibrary.wiley.com/doi/10.1002/ejhf.2575


Chinese expert consensus on the diagnosis and treatment of chronic heart failure in elderly patients (2021)

" In recent years, great progression has been made in the therapy of heart failure, however the prevalence, mortality, and readmission rate amongst senior patients with heart failure continue to be high. Because senior patients have several heart disease risk factors, coexistence of multiple diseases accompanied by multiple disorders, several medications, and natural decline of body functions, the medical diagnosis, treatment, recovery, and long \ u2010term management of these patients differ from those in other populations. ".

Source link: https://onlinelibrary.wiley.com/doi/10.1002/agm2.12215


Promise of sodium–glucose co‐transporter‐2 inhibitors in heart failure with mildly reduced ejection fraction

" Heart failure with slightly minimized ejection portion is connected with equivalent poor end results as other subtypes of heart failure and continues to be a clinical unmet demand due to the scarceness of efficient therapies. According to large cardiovascular result tests in patients with heart failure, sodium \ u2013glucose carbon monoxide \ u2010transporter \ u20102 preventions reduce CV mortality and hospitalizations for heart failure in patients with heart failure throughout the spectrum of left ventricular ejection fraction. A narrative evaluation of trials investigating the effectiveness of each medicine in treating heart failure with LVEF > 40% is offered with an emphasis on their LVEF subgroup evaluations. Current limited proof recommends that SGLT2is may be a good treatment modality for patients with HFmrEF to minimize a hospital stay for heart failure and curriculum vitae mortality. Additional outcome tests entailing adequate patients with different subtypes of HFmrEF are needed to confirm and analyze CV benefits of SGLT2is in HFmrEF. ".

Source link: https://onlinelibrary.wiley.com/doi/10.1002/ehf2.14005


クリニカルシナリオ1急性心不全におけるドクターカーによる病院前硝酸薬投与と救急外来での気管挿管の割合との関連(Association between prehospital nitrates administration and tracheal intubation at emergency department in patients with the Clinical Scenario 1 acute heart failure)

" \ u3010 \ u80cc \ u666f \ u3011Clinical Scenario \ uff08CS \ uff091 \ u5fc3 \ u4e0d \ u5168 \ u306f \ u65e9 \ u6025 \ u306a \ u8840 \ u7ba1 \ u62e1 \ u5f35 \ u3068 \ u547c \ u5438 \ u7ba1 \ u7406 \ u306b \ u3088 \ u308b \ u80ba \ u3046 \ u3063 \ u8840 \ u306e \ u89e3 \ u9664 \ u304c \ u5fc5 \ u8981 \ u3067 \ u3042 \ u308b \ u3002 \ u672c \ u7814 \ u7a76 \ u306e \ u76ee \ u7684 \ u306f \ u30c9 \ u30af \ u30bf \ u30fc \ u30ab \ u30fc \ u306b \ u3088 \ u308b \ u75c5 \ u9662 \ u524d \ u785d \ u9178 \ u85ac \ u6295 \ u4e0e \ u3068 \ u6551 \ u6025 \ u5916 \ u6765 \ u3067 \ u6c17 \ u7ba1 \ u633f \ u7ba1 \ u3055 \ u308c \ u305f \ u5272 \ u5408 \ u3092 \ u691c \ u8a0e \ u3059 \ u308b \ u3053 \ u3068 \ u3067 \ u3042 \ u308b \ u3002 \ u3010 \ u65b9 \ u6cd5 \ u30112015 \ u5e741 \ u6708 \ u304b \ u30892020 \ u5e7412 \ u6708 \ u307e \ u3067 \ u306e \ u9593 \ uff0c \ u5f53 \ u6551 \ u547d \ u6551 \ u6025 \ u30bb \ u30f3 \ u30bf \ u30fc \ u3078 \ u642c \ u9001 \ u3055 \ u308c \ u305fCS1 \ u5fc3 \ u4e0d \ u5168 \ u60a3 \ u8005209 \ u4f8b \ u306e \ u3046 \ u3061 \ uff0c \ u30c9 \ u30af \ u30bf \ u30fc \ u30ab \ u30fc \ u306b \ u3088 \ u308b \ u75c5 \ u9662 \ u524d \ u306b \ u785d \ u9178 \ u85ac \ u3092 \ u6295 \ u4e0e \ u3055 \ u308c \ u305f \ u75c5 \ u9662 \ u524d \ u6295 \ u4e0e \ u7fa4 \ uff0829 \ u4f8b \ uff09 \ u3068 \ u7ba1 \ u8f44 \ u6551 \ u6025 \ u968a \ u306b \ u3088 \ u308a \ u642c \ u9001 \ u3055 \ u308c \ u305f \ u75c5 \ u7740 \ u5f8c \ u306b \ u785d \ u9178 \ u85ac \ u3092 \ u6295 \ u4e0e \ u3055 \ u308c \ u305f \ u75c5 \ u7740 \ u5f8c \ u6295 \ u4e0e \ u7fa4 \ uff08123 \ u4f8b \ uff09 \ u306e \ u4e21 \ u7fa4 \ u3078 \ u5206 \ u3051 \ uff0c \ u75c5 \ u9662 \ u524d \ u785d \ u9178 \ u85ac \ u6295 \ u4e0e \ u306b \ u5bfe \ u3059 \ u308b \ u50be \ u5411 \ u30b9 \ u30b3 \ u30a2 \ u3092 \ u7b97 \ u51fa \ u3057 \ uff0c1 \ u5bfe1 \ u50be \ u5411 \ u30de \ u30c3 \ u30c1 \ u30f3 \ u30b0 \ u3092 \ u884c \ u3063 \ u305f \ u3002 \ u4e3b \ u8981 \ u8a55 \ u4fa1 \ u9805 \ u76ee \ u306f \ u6551 \ u6025 \ u5916 \ u6765 \ u3067 \ u6c17 \ u7ba1 \ u633f \ u7ba1 \ u3055 \ u308c \ u305f \ u5272 \ u5408 \ uff0c \ u526f \ u6b21 \ u8a55 \ u4fa1 \ u9805 \ u76ee \ u306f \ u975e \ u4fb5 \ u8972 \ u7684 \ u967d \ u5727 \ u63db \ u6c17 \ u3068 \ u3057 \ u305f \ u3002 \ u75c5 \ u9662 \ u524d \ u6295 \ u4e0e \ u7fa4 \ u306e \ u904e \ u5ea6 \ u306a \ u8840 \ u5727 \ u4f4e \ u4e0b \ u306b \ u3064 \ u3044 \ u3066 \ u3082 \ u691c \ u8a0e \ u3057 \ u305f \ u3002 \ u3010 \ u7d50 \ u679c \ u3011 \ u50be \ u5411 \ u30b9 \ u30b3 \ u30a2 \ u30de \ u30c3 \ u30c1 \ u30f3 \ u30b0 \ u5f8c \ u306e \ u75c5 \ u9662 \ u524d \ u6295 \ u4e0e \ u7fa4 \ u3068 \ u75c5 \ u7740 \ u5f8c \ u6295 \ u4e0e \ u7fa4 \ u306f \ u3068 \ u3082 \ u306b23 \ u4f8b \ u3067 \ u3042 \ u308a \ uff0c \ u6551 \ u6025 \ u5916 \ u6765 \ u3067 \ u306e \ u6c17 \ u7ba1 \ u633f \ u7ba1 \ u3055 \ u308c \ u305f \ u5272 \ u5408 \ u306f \ u4e21 \ u7fa4 \ u306b \ u6709 \ u610f \ u5dee \ u3092 \ u8a8d \ u3081 \ u306a \ u304b \ u3063 \ u305f \ uff089% vs. 13%, p > 0. 99 \ uff09 \ u3002 \ u975e \ u4fb5 \ u8972 \ u7684 \ u967d \ u5727 \ u63db \ u6c17 \ u306f \ u75c5 \ u9662 \ u524d \ u6295 \ u4e0e \ u7fa4 \ u306b \ u304a \ u3044 \ u3066 \ u6709 \ u610f \ u306b \ u4f4e \ u5024 \ u3067 \ u3042 \ u3063 \ u305f \ uff0848% vs. 83%, p= 0. 03 \ uff09 \ u3002 \ u75c5 \ u9662 \ u524d \ u6295 \ u4e0e \ u7fa4 \ u3067 \ u306f \ u75c5 \ u9662 \ u5230 \ u7740 \ u6642 \ u306b \ u904e \ u5ea6 \ u306a \ u8840 \ u5727 \ u4f4e \ u4e0b \ u3092 \ u8a8d \ u3081 \ u306a \ u304b \ u3063 \ u305f \ u3002 \ u3010 \ u7d50 \ u8a9e \ u3011 \ u672c \ u7814 \ u7a76 \ u3067 \ u306f \ u30c9 \ u30af \ u30bf \ u30fc \ u30ab \ u30fc \ u306b \ u3088 \ u308b \ u75c5 \ u9662 \ u524d \ u785d \ u9178 \ u85ac \ u6295 \ u4e0e \ u306f \ u6551 \ u6025 \ u5916 \ u6765 \ u3067 \ u306e \ u6c17 \ u7ba1 \ u633f \ u7ba1 \ u3055 \ u308c \ u305f \ u5272 \ u5408 \ u3068 \ u6709 \ u610f \ u306a \ u95a2 \ u9023 \ u306f \ u8a8d \ u3081 \ u306a \ u304b \ u3063 \ u305f \ u304c \ uff0c \ u75c5 \ u7740 \ u6642 \ u306e \ u904e \ u5ea6 \ u306a \ u964d \ u5727 \ u306f \ u8a8d \ u3081 \ u306a \ u304b \ u3063 \ u305f \ u3002 ABSTRACT Background: Acute heart failure patients ought to receive vasodilators and oxygen therapy as early as possible. We investigated the association in between prehospital nitrates use and tracheal intubation at the ED in patients with CS1. Techniques: From January 2015 to December 2020, 209 CS1 patients were transported directly from the scene to the Funabashi Municipal Medical. We executed propensity rating matched analysis, a logistic \ u2013regression model was executed to compute a tendency score for nitrates used prehospital. The primary result was the proportion of patients treated with tracheal intubation and the secondary result was the proportion treated with NPPV after arrival at the ED. Results: After matching the patients of the prehospital group and the in \ u2013hospital group, 23 patients were consisted of. Verdict: In this research, prehospital nitrates use was not connected with the increased portion of tracheal intubation after arrival at the ED. ".

Source link: https://onlinelibrary.wiley.com/doi/10.1002/jja2.12708


Knockout of TIGAR enhances myocardial phosphofructokinase activity and preserves diastolic function in heart failure

" In today study, we investigated the role of TIGAR in diastolic function and cardiac fibrosis throughout pressure overload \ u2010induced HF. WT mice based on transverse aortic restriction, a generally used method to cause diastolic disorder, displayed diastolic disorder as shown by increased E/A proportion and E/E \ u2032 ratio when contrasted to its sham controls. Mechanistically, the levels of glucose carrier Glut \ u20101, Glut \ u20104, and crucial glycolytic enzyme phosphofructokinase 1 were significantly raised in TIGAR KO subjected to TAC as compared to that of WT mice. Ko of TIGAR significantly increased fructose 2,6 \ u2010bisphosphate levels and phosphofructokinase task in mouse hearts. On top of that, PO led to a substantial increase in perivascular fibrosis and endothelial activation in the WT mice, however not in the TIGAR KO mice. Our present research recommends a required role of TIGAR \ u2010mediated glucose metabolic process in PO \ u2010induced cardiac fibrosis and diastolic disorder. ".

Source link: https://onlinelibrary.wiley.com/doi/10.1002/jcp.30790


Sex differences in efficacy of pharmacological therapies in heart failure with reduced ejection fraction: a meta‐analysis

" Aims Recent research studies have suggested prospective sex differences in therapy response to medicinal therapies in heart failure. We executed a methodical evaluation and meta \ u2010analysis of researches contrasting treatment impacts between men and women with HF and reduced ejection fraction utilizing established guideline \ u2010directed medical therapy and other arising medicinal therapies. For the composite end result of fatality or HF hospitalization, there was no evidence of treatment heterogeneity by sex for RASi [ HUMAN RESOURCES 0. 84 in men; HR 0. 94 in women; Pinteraction = 0. 210] or BB [HR 0. 76 in men; HUMAN RESOURCES 0. 72 in women; Pinteraction = 0. 650] Results for emerging medicinal therapies, such as soluble guanylate cyclase stimulants and heart myosin activators, were consisted of in the review and revealed consistent therapy impacts in between males and females. Verdicts Our meta \ u2010analysis revealed no distinctions between sex in treatment impact for BB and RASi. ".

Source link: https://onlinelibrary.wiley.com/doi/10.1002/ehf2.13974


Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER‐like endpoint definitions

" The RRR for the composite renal endpoint altered from 22% in the overall population to 40% when patients with EF < 60% were examined. For the composite renal endpoint, the result of empagliflozin ended up being statistically substantial in patients with EF < 60% using the DELIVER interpretation. ".

Source link: https://onlinelibrary.wiley.com/doi/10.1002/ejhf.2558


Apolipoprotein A1 Is Associated with Pulmonary Vascular Resistance and Adverse Clinical Outcomes in Patients with Pulmonary hypertension secondary to Heart Failure

" Pulmonary hypertension secondary to heart failure incorporated with pulmonary vascular remodeling has a high mortality rate. Apolipoprotein A1 has been shown to detrimentally influence outcomes in patients with HF. A prospective adhere to \ u2010up research was performed on 239 successive patients with HF \ u2010PH that went through right heart catheterization. Proteomics innovation was used to examine various proteins in plasma in between post \ u2010 and precapillary pulmonary hypertension and separated postcapillary pulmonary hypertension filteringed system by tendency rating matching. ApoA1 levels in HF \ u2010PH patients with CpcPH were less than those in HF \ u2010PH patients with IpcPH. The patients with lower ApoA1 levels were in a higher NYHA course and had high degrees of NT \ u2010proBNP, pvr, mpap and dpg. Besides, HF \ u2010PH patients with lower ApoA1 degrees had a 2. 836 \ u2010fold higher relative risk of comorbid CpcPH contrasted with patients with higher ApoA1 levels. The survival of HF \ u2010PH patients with lower ApoA1 levels was decreased. ".

Source link: https://onlinelibrary.wiley.com/doi/10.1002/pul2.12096


Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE‐HF trial roll‐in cohort

" In heart failure with preserved ejection fraction, extreme redistribution of blood quantity into the central blood circulation causes altitudes of intracardiac stress with exercise constraints. Patients with HF, left ventricular ejection fraction \ u226550%, and invasive optimal workout pulmonary capillary wedge pressure \ u226525 mmHg underwent SAVM. Right here we report on the first 18 patients with HFpEF that have been registered into the roll \ u2010in, open \ u2010label arm of the research across 9 centres; 14 female; 16 in NYHA class III; and average age 75. 2 years, LVEF 61. 0 %, and average 20 W workout PCWP 36. 4 mmHg. At 1 \ u2010month, the mean PCWP at 20 W exercise decreased from 36. 4 to 28. 9 mmHg, NYHA class boosted by at least one course in 33% of patients and KCCQ rack up improved by 22. 1 points. Final thought The initial open \ u2010label arise from the multicentre REBALANCE \ u2010HF roll \ u2010in cohort sustain the security and efficacy of SAVM in HFpEF. ".

Source link: https://onlinelibrary.wiley.com/doi/10.1002/ejhf.2559

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions